The peptide exhibits consistent efficacy in models of acute and chronic injury regardless of administration route (intraperitoneal, oral, or local application), a unique characteristic distinguishing it from other growth factors that typically require localized delivery with carrier systems
However, some have parallel primary care clinicians in the same practice with panels of patients, but it is very limited
Clin Genitourin Cancer
The FDAs own language makes it clear: Compounded drugs containing BPC-157 may pose risk for immunogenicity and may have complexities with regard to peptide-related impurities and API characterization. In plain terms, the FDA is worried about shady, unregulated research-use-only peptides sold online not about what happens when BPC-157 is responsibly compounded, tested for purity, and dispensed under medical supervision
How does a peptide that clears your system within hours produce lasting tissue changes
*Source: Survey conducted among small animal veterinarians who recommended animal supplements.